T-Cell Lymphoblastic Leukemia/Lymphoma: Relapse 16 Years after First Remission

T-Cell Lymphoblastic Leukemia/Lymphoma: Relapse 16 Years after First Remission

Little information is available regarding late relapse in patients with T-lymphoblastic leukemia/lymphoma (T-LBL). Because of the aggressive nature of this disease, relapse is common and often happens early. Late relapses are rare and generally occur within a few years after initial remission. The r...

Full description

Bibliographic Details
Main Authors: Lauren Elreda, Manpreet Sandhu, Xinlai Sun, Wondwessen Bekele, Alice J. Cohen, Maya Shah
Format: Article
Language:English
Published: Hindawi Limited 2014-01-01
Series:Case Reports in Hematology
Online Access:http://dx.doi.org/10.1155/2014/359158
id doaj-eb0f457dd7af4d71b344bee79bbdad91
record_format Article
spelling doaj-eb0f457dd7af4d71b344bee79bbdad912020-11-24T21:26:44ZengHindawi LimitedCase Reports in Hematology2090-65602090-65792014-01-01201410.1155/2014/359158359158T-Cell Lymphoblastic Leukemia/Lymphoma: Relapse 16 Years after First RemissionLauren Elreda0Manpreet Sandhu1Xinlai Sun2Wondwessen Bekele3Alice J. Cohen4Maya Shah5Department of Medicine, Hematology/Oncology, Newark Beth Israel Medical Center, Saint Barnabas Health Care System, Newark, NJ 07112, USADepartment of Medicine, Hematology/Oncology, Newark Beth Israel Medical Center, Saint Barnabas Health Care System, Newark, NJ 07112, USADepartment of Laboratory Medicine and Pathology, Newark Beth Israel Medical Center, Saint Barnabas Health Care System, Newark, NJ 07112, USADepartment of Pediatrics, Hematology/Oncology, Newark Beth Israel Medical Center, Saint Barnabas Health Care System, Newark, NJ 07112, USADepartment of Medicine, Hematology/Oncology, Newark Beth Israel Medical Center, Saint Barnabas Health Care System, Newark, NJ 07112, USADepartment of Medicine, Hematology/Oncology, Newark Beth Israel Medical Center, Saint Barnabas Health Care System, Newark, NJ 07112, USALittle information is available regarding late relapse in patients with T-lymphoblastic leukemia/lymphoma (T-LBL). Because of the aggressive nature of this disease, relapse is common and often happens early. Late relapses are rare and generally occur within a few years after initial remission. The relapse rate after 3 years has been reported to steadily decrease over time yet does not parallel with cure. We report a case of a 26-year-old female with T-LBL and relapse 16 years after her first remission with successful treatment with HyperCVAD and L-asparaginase.http://dx.doi.org/10.1155/2014/359158
collection DOAJ
language English
format Article
sources DOAJ
author Lauren Elreda
Manpreet Sandhu
Xinlai Sun
Wondwessen Bekele
Alice J. Cohen
Maya Shah
spellingShingle Lauren Elreda
Manpreet Sandhu
Xinlai Sun
Wondwessen Bekele
Alice J. Cohen
Maya Shah
T-Cell Lymphoblastic Leukemia/Lymphoma: Relapse 16 Years after First Remission
Case Reports in Hematology
author_facet Lauren Elreda
Manpreet Sandhu
Xinlai Sun
Wondwessen Bekele
Alice J. Cohen
Maya Shah
author_sort Lauren Elreda
title T-Cell Lymphoblastic Leukemia/Lymphoma: Relapse 16 Years after First Remission
title_short T-Cell Lymphoblastic Leukemia/Lymphoma: Relapse 16 Years after First Remission
title_full T-Cell Lymphoblastic Leukemia/Lymphoma: Relapse 16 Years after First Remission
title_fullStr T-Cell Lymphoblastic Leukemia/Lymphoma: Relapse 16 Years after First Remission
title_full_unstemmed T-Cell Lymphoblastic Leukemia/Lymphoma: Relapse 16 Years after First Remission
title_sort t-cell lymphoblastic leukemia/lymphoma: relapse 16 years after first remission
publisher Hindawi Limited
series Case Reports in Hematology
issn 2090-6560
2090-6579
publishDate 2014-01-01
description Little information is available regarding late relapse in patients with T-lymphoblastic leukemia/lymphoma (T-LBL). Because of the aggressive nature of this disease, relapse is common and often happens early. Late relapses are rare and generally occur within a few years after initial remission. The relapse rate after 3 years has been reported to steadily decrease over time yet does not parallel with cure. We report a case of a 26-year-old female with T-LBL and relapse 16 years after her first remission with successful treatment with HyperCVAD and L-asparaginase.
url http://dx.doi.org/10.1155/2014/359158
work_keys_str_mv AT laurenelreda tcelllymphoblasticleukemialymphomarelapse16yearsafterfirstremission
AT manpreetsandhu tcelllymphoblasticleukemialymphomarelapse16yearsafterfirstremission
AT xinlaisun tcelllymphoblasticleukemialymphomarelapse16yearsafterfirstremission
AT wondwessenbekele tcelllymphoblasticleukemialymphomarelapse16yearsafterfirstremission
AT alicejcohen tcelllymphoblasticleukemialymphomarelapse16yearsafterfirstremission
AT mayashah tcelllymphoblasticleukemialymphomarelapse16yearsafterfirstremission
_version_ 1725977784855035904

Similar Items